Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 7 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 10711257

    Modified cascade ribonucleoproteins and uses thereof

    Caribou Biosciences, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  2. US 10676740

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  3. US 10668170

    Modified RNAi agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  4. US 10654864

    Modified cytotoxins and their therapeutic use

    The Regents of the University of California · Granted May 19, 2020 · Expires May 14, 2040

    granted

  5. US 10633654

    Modified RNAi polynucleotides and uses thereof

    Phio Pharmaceuticals Corp. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  6. US 10624959

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  7. US 10612027

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  8. US 10612024

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  9. US 10596260

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  10. US 10563094

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  11. US 10561126

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  12. US 10525126

    Modified lipopolysaccharide glycoform and method of use

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  13. US 10501558

    Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  14. US 10463028

    Genetically modified non-human animals expressing human EPO

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted

  15. US 10442789

    Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

    Sutro Biopharma, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  16. US 10435678

    Modified cascade ribonucleoproteins and uses thereof

    Caribou Biosciences, Inc. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  17. US 10435677

    Genetically modified human cell with a corrected mutant sickle cell mutation

    Sangamo Therapeutics, Inc. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  18. US 10415044

    Adeno-associated virus vectors encoding modified G6PC and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  19. US 10406177

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  20. US 10391126

    CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  21. US 10392430

    Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  22. US 10385319

    Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  23. US 10370679

    Modified immunization vectors

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  24. US 10344281

    Functionally-modified oligonucleotides and subunits thereof

    Sarepta Therapeutics, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.